Cargando…

The impact of artificial intelligence in the diagnosis and management of glaucoma

Deep learning (DL) is a subset of artificial intelligence (AI), which uses multilayer neural networks modelled after the mammalian visual cortex capable of synthesizing images in ways that will transform the field of glaucoma. Autonomous DL algorithms are capable of maximizing information embedded i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayro, Eileen L., Wang, Mengyu, Elze, Tobias, Pasquale, Louis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002653/
https://www.ncbi.nlm.nih.gov/pubmed/31541215
http://dx.doi.org/10.1038/s41433-019-0577-x
_version_ 1783494406571032576
author Mayro, Eileen L.
Wang, Mengyu
Elze, Tobias
Pasquale, Louis R.
author_facet Mayro, Eileen L.
Wang, Mengyu
Elze, Tobias
Pasquale, Louis R.
author_sort Mayro, Eileen L.
collection PubMed
description Deep learning (DL) is a subset of artificial intelligence (AI), which uses multilayer neural networks modelled after the mammalian visual cortex capable of synthesizing images in ways that will transform the field of glaucoma. Autonomous DL algorithms are capable of maximizing information embedded in digital fundus photographs and ocular coherence tomographs to outperform ophthalmologists in disease detection. Other unsupervised algorithms such as principal component analysis (axis learning) and archetypal analysis (corner learning) facilitate visual field interpretation and show great promise to detect functional glaucoma progression and differentiate it from non-glaucomatous changes when compared with conventional software packages. Forecasting tools such as the Kalman filter may revolutionize glaucoma management by accounting for a host of factors to set target intraocular pressure goals that preserve vision. Activation maps generated from DL algorithms that process glaucoma data have the potential to efficiently direct our attention to critical data elements embedded in high throughput data and enhance our understanding of the glaucomatous process. It is hoped that AI will realize more accurate assessment of the copious data encountered in glaucoma management, improving our understanding of the disease, preserving vision, and serving to enhance the deep bonds that patients develop with their treating physicians.
format Online
Article
Text
id pubmed-7002653
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70026532020-06-08 The impact of artificial intelligence in the diagnosis and management of glaucoma Mayro, Eileen L. Wang, Mengyu Elze, Tobias Pasquale, Louis R. Eye (Lond) Review Article Deep learning (DL) is a subset of artificial intelligence (AI), which uses multilayer neural networks modelled after the mammalian visual cortex capable of synthesizing images in ways that will transform the field of glaucoma. Autonomous DL algorithms are capable of maximizing information embedded in digital fundus photographs and ocular coherence tomographs to outperform ophthalmologists in disease detection. Other unsupervised algorithms such as principal component analysis (axis learning) and archetypal analysis (corner learning) facilitate visual field interpretation and show great promise to detect functional glaucoma progression and differentiate it from non-glaucomatous changes when compared with conventional software packages. Forecasting tools such as the Kalman filter may revolutionize glaucoma management by accounting for a host of factors to set target intraocular pressure goals that preserve vision. Activation maps generated from DL algorithms that process glaucoma data have the potential to efficiently direct our attention to critical data elements embedded in high throughput data and enhance our understanding of the glaucomatous process. It is hoped that AI will realize more accurate assessment of the copious data encountered in glaucoma management, improving our understanding of the disease, preserving vision, and serving to enhance the deep bonds that patients develop with their treating physicians. Nature Publishing Group UK 2019-09-20 2020-01 /pmc/articles/PMC7002653/ /pubmed/31541215 http://dx.doi.org/10.1038/s41433-019-0577-x Text en © The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2019
spellingShingle Review Article
Mayro, Eileen L.
Wang, Mengyu
Elze, Tobias
Pasquale, Louis R.
The impact of artificial intelligence in the diagnosis and management of glaucoma
title The impact of artificial intelligence in the diagnosis and management of glaucoma
title_full The impact of artificial intelligence in the diagnosis and management of glaucoma
title_fullStr The impact of artificial intelligence in the diagnosis and management of glaucoma
title_full_unstemmed The impact of artificial intelligence in the diagnosis and management of glaucoma
title_short The impact of artificial intelligence in the diagnosis and management of glaucoma
title_sort impact of artificial intelligence in the diagnosis and management of glaucoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002653/
https://www.ncbi.nlm.nih.gov/pubmed/31541215
http://dx.doi.org/10.1038/s41433-019-0577-x
work_keys_str_mv AT mayroeileenl theimpactofartificialintelligenceinthediagnosisandmanagementofglaucoma
AT wangmengyu theimpactofartificialintelligenceinthediagnosisandmanagementofglaucoma
AT elzetobias theimpactofartificialintelligenceinthediagnosisandmanagementofglaucoma
AT pasqualelouisr theimpactofartificialintelligenceinthediagnosisandmanagementofglaucoma
AT mayroeileenl impactofartificialintelligenceinthediagnosisandmanagementofglaucoma
AT wangmengyu impactofartificialintelligenceinthediagnosisandmanagementofglaucoma
AT elzetobias impactofartificialintelligenceinthediagnosisandmanagementofglaucoma
AT pasqualelouisr impactofartificialintelligenceinthediagnosisandmanagementofglaucoma